In this interview with Cisco, María Artunduaga, CEO and founder of Respira Labs, details how their technology aimed at monitoring respiratory health can enhance the lives of COPD, asthma and COVID-19 patients and prevent hospitalizations.
Respira Labs, second runner-up of the Cisco Global Problem Solver Challenge 2020, is developing a technology that can help patients living with respiratory diseases monitor their lung function. Their device, Sylvee, is aimed at solving the current problem of late treatment and hospitalization from patients suffering from COPD, asthma and COVID-19 related issues. Respiratory problems have increased around the world as a result of the pandemic, and an accurate home-based monitoring technology like Sylvee seeks to provide doctors and patients with information about lung health remotely and in real time. Dr. Artunduaga started working on this revolutionary technology after the death of her grandmother, a COPD patient who failed to get treatment in time because she couldn’t detect her symptoms.
The prize money will help Respira Labs accelerate their product development and get to market earlier, which will increase respiratory patients’ quality of life as long COVID-19 conditions hit thousands.